The expression and activity of MMPs are increased in residual tumor tissues after the termination of immunotherapy

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 4, 2008, Pages 375-378

  Xiong, Ting ^a   Peng, Huimin ^a   Chen, Guoxi ^a   Yuan, Ye ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Immunotherapy; Interferon ; Matrix metalloproteinases; Tumor metastasis

Indexed keywords

CH50 RECOMBINANT POLYPEPTIDE; FIBRONECTIN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; EXPERIMENTAL MELANOMA; FEMALE; GENE THERAPY; GENETICS; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ANIMALS; COMBINED MODALITY THERAPY; FEMALE; FIBRONECTINS; GENETIC THERAPY; IMMUNOTHERAPY; INTERFERON-GAMMA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS;

EID: 49749139313     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0401-5     Document Type: Article

References (17)

1. Xiao H, Huang B, Yuan Y et al. PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo. Clin Cancer Res, 2007,13:1823-1830
2. Cheng Y, Dong Q, Sun L R et al. Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma. Chin J Oncol, 2005,27(3):164-166
3. Kerkelä E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol, 2003,12:109-125
4. He Y F, Zhang G M, Wang X H et al. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol, 2004,173:4919-4928
5. He Y F, Wang X H, Zhang G M et al. Sustained low-level expression of interferon-γ promotes tumor development: Potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother, 2005,54:891-897
6. Liu Y, Huang B, Yuan Y et al. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int J Cancer. 2007;121:184-192.
7. Yoshida H, Katayose Y, Unno M et al. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity. Cancer Immunol Immunother, 2003,52:97-106
8. Yurkovetsky Z R, Shurin G V, Barry D A et al. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells. J Gene Med, 2006,8:129-137
9. Cheuk A T, Mufti G J, Guinn B A. Role of 4-1BB:4-1BB ligand in cancer immunotherapy. Cancer Gene Ther, 2004,11:215-226
10. Gollob J A, Sciambi C J, Huang Z et al. Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma. Cancer Res, 2005,65:8869-8877
11. Karmakar S, Dhar R, Das C. Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. J Biol Chem, 2004, 279:55297-55307
12. Belperio J A, Keane M P, Arenberg D A et al. CXC chemokines in angiogenesis. J Leukocyte Biol, 2000,68:1-8
13. Dias S, Boyd R, Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer, 1998,78:361-365
14. Mitola S, Strasly M, Prato M et al. IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. J Immunol, 2003,171:3725-3733
15. Rüegg C, Yilmaz A, Bieler G et al. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med, 1998,4:408-414
16. Strasly M, Cavallo F, Geuna M et al. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol, 2001,166:3890-3899
17. Yu Z R, Zhang G M, Li D et al. The inhibitory effect of recombinant polypeptide CH50 of fibronectin on invasion and angiogenesis of tumors. Chin J Oncol, 2006,28(11):815-819